Synopsis
The global market for Genomics Software was estimated to be worth US$ 311 million in 2024 and is forecast to a readjusted size of US$ 533 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Genomics technology will generate a lot of data and information, which is unprecedented in the history of biology. Genomics Software is used to handle the collection, storage, analysis and integration of these data. Genomics Software usually includes the function or modules of sequencing, microarray, gene expression, clinical data workflows and data analysis.
Global core genomics software players include Agilent Technologies, QIAGEN Digital Insights, SAS (JMP Genomics) etc. The largest company hold a share about 35%. North America is the largest market, with a share about 53%, followed by Europe and Asia-Pacific with the share about 24% and 19%.
In terms of product, on-premise is the largest segment, with a share over 78%. And in terms of application, the largest application is hospitals and health systems, followed by research organizations.
Market Drivers
Advancements in Next-Generation Sequencing (NGS) Technologies: Declining costs of DNA sequencing (e.g., Illumina, PacBio, Oxford Nanopore) drive demand for bioinformatics tools to analyze large datasets. Long-read sequencing and single-cell sequencing require advanced software for data processing.
Increasing Demand for Precision Medicine & Personalized Healthcare: Cancer genomics, pharmacogenomics, and rare disease research rely on genomics software for variant analysis. Clinical decision support tools integrate genomic data into patient care (e.g., IBM Watson Genomics, Tempus).
Growth of AI and Machine Learning in Genomics: AI-powered variant calling, genome annotation, and drug discovery (e.g., DeepVariant, DNAnexus). Predictive analytics for disease risk assessment and treatment optimization.
This report aims to provide a comprehensive presentation of the global market for Genomics Software, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Genomics Software by region & country, by Type, and by Application.
The Genomics Software market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomics Software.
Market Segmentation
By Company
Agilent Technologies
SAS (JMP Genomics)
Thermo Fisher Scientific
QIAGEN Digital Insights
DNASTAR
Fabric Genomics
Biomatters (Geneious)
Illumina
DNAnexus
Bionano
Golden Helix
10x Genomics
Segment by Type
On-Premise
Cloud Based
Segment by Application
Hospitals and Health Systems
Research Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Genomics Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Genomics Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Genomics Software in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Index
Available Upon Request